高级检索
当前位置: 首页 > 详情页

Therapeutic potential of naringin: an overview

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Medical Faculty, Kunming University of Science and Technology, Kunming, Yunnan Province, China [2]The First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China [3]Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan Province, China [4]Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Dali, Yunnan Province, China
出处:
ISSN:

关键词: Pharmacological action bone regeneration anti-inflammatory anti-cancer extraction technology controlled release formulations

摘要:
Context: Naringin is a natural flavanone glycoside that is found in the Chinese herbal medicines and citrus fruits. Studies have demonstrated that naringin possesses numerous biological and pharmacological properties, but few reviews of these studies have been performed. Objective: The present review gathers the fragmented information available in the literature describing the extraction of naringin, its pharmacology and its controlled release formulations. Current research progress and the therapeutic potential of naringin are also discussed. Methods: A literature survey for relevant information regarding the biological and pharmacological properties of naringin was conducted using Pubmed, Sciencedirect, MEDLINE, Springerlink and Google Scholar electronic databases from the year 2007-2015. Results: Naringin modulates signalling pathways and interacts with signalling molecules and thus has a wide range of pharmacological activities, including anti-inflammatory, anti-cancer activities, as well as effects on bone regeneration, metabolic syndrome, oxidative stress, genetic damage and central nervous system (CNS) diseases. Information was gathered that showed the extraction of naringin can be improved using several modifications. There has been some progress in the development of controlled release formulations of naringin. Conclusion: Naringin is a promising candidate for further in vivo studies and clinical use. More detailed studies regarding its mechanism of action are required.

基金:
语种:
高被引:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学实验技术 4 区 药学 4 区 植物科学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 医学实验技术 2 区 药学 2 区 植物科学
JCR分区:
出版当年[2015]版:
Q2 PLANT SCIENCES Q3 PHARMACOLOGY & PHARMACY Q3 MEDICAL LABORATORY TECHNOLOGY
最新[2023]版:
Q1 MEDICAL LABORATORY TECHNOLOGY Q1 PLANT SCIENCES Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Medical Faculty, Kunming University of Science and Technology, Kunming, Yunnan Province, China [2]The First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China [3]Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan Province, China
通讯作者:
通讯机构: [1]Medical Faculty, Kunming University of Science and Technology, Kunming, Yunnan Province, China [2]The First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China [3]Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan Province, China [*1]the First People's Hospital of Yunnan Province, Kunming, Yunnan Province, 650032, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:81493 今日访问量:0 总访问量:676 更新日期:2024-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号